Get informed when a big investor buys or sells
+ FollowOvervalued by 107.1% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $1.07 Million |
|---|---|
| Enterprise Value | $1.23 Million |
| Annual dividend | $0.01 |
| Earnings per Share | $0 |
| Beta | 2.63 |
| Outstanding Shares | 733,760,409 |
| P/E Ratio | -0.48 |
|---|---|
| PEG | -0.02 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 26205.53 |
| Enterprise Value to EBIT | -7.31 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | -0.21 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Fifty 1 Labs, Inc. is a Nevada-based holding company that has shifted its focus to biotechnology and telehealth, centering on peptide science for musculoskeletal health, recovery, and performance. The company utilizes AI-driven research ...